SpineSports Medicine

Oxford Performance Materials Announces Agreement with Fuse Medical to Develop New Spinal and Sports Medicine Implants

Fuse to Utilize OPM’s OsteoFab® Technology for Development of Unique 3D Printed PEKK Product Lines.


Oxford Performance Materials, Inc. (OPM), an industry leader in advanced polymer science and 3D printed orthopedic devices, announced today an agreement with Fuse Medical, Inc. (Fuse) a manufacturer and distributor of innovative medical devices, to develop new, world-class spinal, extremity and sports medicine implant product lines utilizing OPM’s patented OsteoFab® PEKK technology.

The agreement between the companies enables Fuse to develop new cervical and lumbar spinal interbodies, soft tissue fixation devices for sports medicine, and other foot and ankle implants featuring OPM’s proprietary 3D printing IP, delivering a proven set of clinical benefits to the surgeon that are unique to the OsteoFab technology: bone like mechanics, bone ongrowth, radiolucency, and antibacterial + antiviral properties, all produced with OPM’s (metal and metallosis-free) OXPEKK® material formulation. Fuse will be Original Equipment Manufacturer of the new product lines, which OPM will exclusively contract manufacture.

“As OPM focuses on providing advanced implantable polymers and contract manufacturing services, we look to work with industry leaders that are dedicated to innovative solutions that drive medical device technology forward in ways that reduce system costs and improve patient outcomes,” said OPM founder & CEO Scott DeFelice. “Fuse clearly fits this mold, and we are extremely pleased to be making this important partnership announcement.”

Fuse CEO Chris Reeg commented, “This new collaboration with OPM continues our mission to develop unique, differentiated products and technologies with breakout potential. Over the past year, Fuse has developed a deep scientific understanding of OPM’s OsteoFab PEKK technology, and our team is extremely excited about developing new product lines in spine, sports medicine, and foot and ankle that feature OsteoFab’s unique set of clinical benefits.”

About Oxford Performance Materials, Inc.
Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK® brand, including coating technologies for a range of industrial and biomedical applications. The Company is a pioneer in 3D printing. OPM’s OsteoFab® technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM’s OXFAB® production parts are designed for highly demanding industrial applications. Learn more at http://www.oxfordpm.com or info@oxfordpm.com

About Fuse Medical, Inc.
Fuse is an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace. Fuse provides a comprehensive portfolio of products in the spine, total joint, sports medicine, upper and lower extremities space, as well as osteobiologics, wound care, and regenerative products. For more information about the Company, or if you’re interested in becoming a distributor of any Fuse’s products, please contact us at info@fusemedical.com or visit: http://www.fusemedical.com.

Company Contacts:

For OPM:
Bernard Plishtin

For Fuse:
Kenneth Walker

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button